Heghine Khachatryan: Strengthening Maternal Resilience Against Postpartum Hemorrhage
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared End Postpartum Hemorrhage’s post on LinkedIn, adding:
”Postpartum Hemorrhage (PPH) remains a leading cause of maternal mortality worldwide — and anaemia is a critical, yet often underestimated, contributor.
Strengthening maternal resilience requires a systems-based approach:
- Early identification and treatment of iron deficiency and anaemia during pregnancy
- Structured risk stratification for bleeding
- Access to safe and sufficient blood products
- Integration of haemostasis expertise into obstetric care
- Multidisciplinary emergency preparedness protocols
In many low- and middle-income settings, the intersection of anaemia, limited transfusion capacity, and delayed haemorrhage control creates a preventable cascade of morbidity and mortality.
Addressing PPH is not only about emergency management — it is about prevention, preparedness, and equitable access to diagnostics and treatment.
As hematologists and health policy advocates, we must actively contribute to strengthening national strategies that integrate maternal haemostasis, blood systems, and public health infrastructure.
Maternal survival is a measure of health system equity.”
Quoting End Postpartum Hemorrhage’s post:
”Strengthening Maternal Resilience: Postpartum Haemorrhage (PPH) remains the leading cause of maternal mortality in Kenya.
A critical factor often overlooked is pre-existing anaemia. Addressing this at the antenatal stage is a cost-effective, high-impact strategy for reducing deaths.”
Find more posts featuring Heghine Khachatryan on Hemostasis Today.
-
Jul 2, 2026, 18:47Vee Townsend: IMHUE Highlights 9 Myths and Facts About Hemophilia B
-
Jul 2, 2026, 17:17Nico Gagelmann: Launching Myths and Facts on Hematology and Cell Therapy
-
Jul 2, 2026, 17:05Haroun Gajraj: Understanding the Technology Behind Spider Vein Treatment
-
Jul 2, 2026, 16:44Ney Carter Borges: Is It Time to Personalize Antiplatelet Therapy?
-
Jul 2, 2026, 16:22Introducing a New Resource for the ITP Community – ITP Support Association
-
Jul 2, 2026, 16:22Shinto Francis Thekkudan: Delegates Visiting our BMT and Hematology Department from Kazhakstan
-
Jul 2, 2026, 16:13William Aird: When Deciding whether an Adult Patient is Anemic, Which Do You Usually Use?
-
Jul 2, 2026, 16:08Supporting Bleeding Disorders Community and Celebrating ASPEH Milestone – WFH
-
Jul 2, 2026, 15:59Raul Santos: Why Does LDL-C Remain Elevated in Many Patients?